Ipilimumab/nivolumabHypophysitis, hypothyroidism and adrenal insufficiency: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1852卷 / 1期

关键词：

D O I：

10.1007/s40278-021-94700-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：247 / 247

相关论文

共 50 条

[31] Ipilimumab/nivolumabPrimary adrenal insufficiency and acute cardiomyopathy: case report
[J]. Reactions Weekly, 2022, 1893 (1) : 192 - 192
[32] Ipilimumab/nivolumabCentral adrenal insufficiency due to hypophysitis: case report
[J]. Reactions Weekly, 2019, 1775 (1) : 268 - 268
[33] Ipilimumab/nivolumabThyroiditis, cardiac arrest and adrenal insufficiency: case report
[J]. Reactions Weekly, 2021, 1853 (1) : 258 - 258
[34] Ipilimumab/nivolumabHypophysitis and type 1 diabetes: case report
[J]. Reactions Weekly, 2016, 1608 (1) : 160 - 160
[35] Ipilimumab/NivolumabGrade 1 hypothyroidism and grade 3 secondary adrenal insufficiency
[J]. Reactions Weekly, 2023, 1985 (1) : 272 - 272
[36] Ipilimumab/NivolumabHypophysitis
[J]. Reactions Weekly, 2024, 2003 (1) : 477 - 477
[37] Ipilimumab/nivolumabHypophysitis: 3 case reports
[J]. Reactions Weekly, 2020, 1833 (1) : 216 - 216
[38] Ipilimumab/nivolumabHypophysitis: 25 case reports
[J]. Reactions Weekly, 2021, 1859 (1) : 197 - 197
[39] Ipilimumab/nivolumabHypophysitis: 5 case reports
[J]. Reactions Weekly, 2017, 1639 (1) : 169 - 169
[40] Ipilimumab/nivolumabHypophysitis and Raynaud's-like phenomenon: case report
[J]. Reactions Weekly, 2020, 1816 (1) : 190 - 190

← 1 2 3 4 5 →